New study offers hope to patients with advanced liver cancer, cirrhosis
The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is replaced by scar tissue. The scar tissue blocks the flow of blood through the liver and keeps it from functioning as it should, and patients with advanced liver cancer and cirrhosis are normally considered unsuitable for surgery or transplant.
In a new study published in the British Journal of Surgery, researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.
“Our study describes how a minimally invasive surgical approach known as the Arantius-first technique, can be applied in high-risk populations, potentially expanding surgical indications for patients with cirrhosis,” explains corresponding author Eduardo Vega, MD, assistant professor of surgery at Boston University Chobanian & Avedisian School of Medicine. The Arantius-first technique is a laparoscopic procedure that uses the Arantius' ligament as an anatomical landmark to quickly expose the middle hepatic vein (MHV).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.